Magnetic Resonance in Intravenous Magnesium Efficacy in Stroke Trial: MR Images "MR IMAGES"

Completed

Phase N/A Results

Summary of Purpose

To determine whether intravenous magnesium sulfate initiated within 12 hours of symptom onset will reduce the frequency of infarct growth, as measured by MRI, in ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 May 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Institute for Neurological Disorders and Stroke, NIH

Trial Design

Randomized, double-blind, placebo-controlled, multicenter trial. This is an MRI substudy of the IMAGES trial.

Contacts

Not available